Probi Ab Stock Fundamentals

PROB Stock  SEK 350.00  1.00  0.28%   
Probi AB fundamentals help investors to digest information that contributes to Probi AB's financial success or failures. It also enables traders to predict the movement of Probi Stock. The fundamental analysis module provides a way to measure Probi AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Probi AB stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Probi AB Company Return On Equity Analysis

Probi AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Probi AB Return On Equity

    
  0.0304  
Most of Probi AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Probi AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Probi AB has a Return On Equity of 0.0304. This is 100.13% lower than that of the Biotechnology sector and 100.08% lower than that of the Health Care industry. The return on equity for all Sweden stocks is 109.81% lower than that of the firm.

Probi AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Probi AB's current stock value. Our valuation model uses many indicators to compare Probi AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Probi AB competition to find correlations between indicators driving Probi AB's intrinsic value. More Info.
Probi AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.69  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Probi AB is roughly  1.44 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Probi AB's earnings, one of the primary drivers of an investment's value.

Probi Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Probi AB's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Probi AB could also be used in its relative valuation, which is a method of valuing Probi AB by comparing valuation metrics of similar companies.
Probi AB is currently under evaluation in return on equity category among its peers.

Probi Fundamentals

About Probi AB Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Probi AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Probi AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Probi AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Probi AB , a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies. The company was founded in 1991 and is headquartered in Lund, Sweden. Probi AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 164 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Probi Stock Analysis

When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.